Anthem Blue Cross and Blue Shield Virginia prior authorization code reference, page 78

Source code lookup

Each row links an imported source code to its service or category label. Check the original document for the complete plan scope, review type and qualifications.

Source code index

Imported source codes and labels; verify the complete review requirements in the original document
CodeDescriptionSource
S9480Intensive Outpatient PsychiaVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 81 Original policy
S9490Home infusion therapy, corticosteroid infusion; administrative services, professional pharmacy services, care coordinatiVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 81 Original policy
S9494Home infusion therapy, antibiotic, antiviral, or antifungal therapy (do not use with home infusion codes for hourly dosiVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 81 Original policy
S9497Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every three hoursVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 81 Original policy
S9500Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 24 hoursVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
S9501Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 12 hoursVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
S9502Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 8 hoursVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
S9503Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every six hoursVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
S9504Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every four hoursVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
S9542Home injectable therapy; not otherwise classifiedVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
S9810Home therapy; professional pharmacy service for provision of infusion, specialty drug administration, and/or disease staVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
S9960Ambulance service, conventional air services, nonemergency transport, one way (fixed wing)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
S9961Ambulance service, conventional air service, nonemergency transport, one way (rotary wing)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
T1001Nursing assessment/evaluationVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
T1002RN services, up to 15 minutesVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
T1003LPN/LVN services, up to 15 minutesVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
T1004Services of a qualified nursing aide, up to 15 minutesVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
T1021Home Health Aide Or Certified Nurse Assistant, Per VisitVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
T1022Contracted Home Health Agency Services, All Services Provided Under CoVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
T2036Therapeutic camping, overnight, waiver; each sessionVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
T2037Therapeutic camping, day, waiver; each sessionVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
V2787Astigmatism correcting function of intraocular lensVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
V2788Presbyopia correcting function of intraocular lensVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
V2790Amniotic MembraneVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
V5095Semi-Implantable Middle Ear Hearing ProsthesisVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
V5298Hearing Aid, Not Otherwise ClassifiedVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
V5362Speech ScreeningVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
V5363Language ScreeningVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
V5364Dysphagia ScreeningVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 82 Original policy
0417TProgramming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed valuesVirginia PPO standard precertification/prior authorization requirements, Pg 6 Original policy
0417URare diseases (constitutional/heritable disorders), whole mitochondrial genome sequence with heteroplasmy detection and deletion analysis, nuclear-encoded mitochondrial gene aVirginia PPO standard precertification/prior authorization requirements, Pg 6 Original policy
0418TInterrogation device evaluation (in person) with analysis, review and report, includes connection, recording and disconnection per patient encounter, implantable cardiac contrVirginia PPO standard precertification/prior authorization requirements, Pg 6 Original policy
0419UNeuropsychiatry (eg, depression, anxiety), genomic sequence analysis panel, variant analysis of 13 genes, saliva or buccal swab, report of each gene phenotypeVirginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0420UOncology (urothelial), mRNA expression profiling by real-time quantitative PCR of MDK, HOXA13, CDC2, IGFBP5, and CXCR2 in combination with droplet digital PCR (ddPCR) analysisVirginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0422UOncology (pan-solid tumor), analysis of DNA biomarker response to anti-cancer therapy using cell-free circulating DNA, biomarker comparison to a previous baseline pre-treatmenVirginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0424UOncology (prostate), exosome-based analysis of 53 small noncoding RNAs (sncRNAs) by quantitative reverse transcription polymerase chain reaction (RT-qPCR), urine, reported asVirginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0425UGenome (eg, unexplained constitutional or heritable disorder or syndrome), rapid sequence analysis, each comparator genome (eg, parents, siblings)Virginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0426UGenome (eg, unexplained constitutional or heritable disorder or syndrome), ultra-rapid sequence analysisVirginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0433UOncology (prostate), 5 DNA regulatory markers by quantitative PCR, whole blood, algorithm, including prostate-specific antigen, reported as likelihood of cancerVirginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0434UDrug metabolism (adverse drug reactions and drug response), genomic analysis panel, variant analysis of 25 genes with reported phenotypesVirginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0435UOncology, chemotherapeutic drug cytotoxicity assay of cancer stem cells (CSCs), from cultured CSCs and primary tumor cells, categorical drug response reported based on cytotoxVirginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0437UPsychiatry (anxiety disorders), mRNA, gene expression profiling by RNA sequencing of 15 biomarkers, whole blood, algorithm reported as predictive risk scoreVirginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0438UDrug metabolism (adverse drug reactions and drug response), buccal specimen, gene-drug interactions, variant analysis of 33 genes, including deletion/duplication analysis of CVirginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0439UCardiology (coronary heart disease [CHD]), DNA, analysis of 5 single-nucleotide polymorphisms (SNPs) (rs11716050 [LOC105376934], rs6560711 [WDR37], rs3735222 [SCIN/LOC10798676Virginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0440TAblation, percutaneous, cryoablation, includes imaging guidance; upper extremity distal/peripheral nerveVirginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0440UCardiology (coronary heart disease [CHD]), DNA, analysis of 10 single-nucleotide polymorphisms (SNPs) (rs710987 [LINC010019], rs1333048 [CDKN2B-AS1], rs12129789 [KCND3], rs942Virginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0441TAblation, percutaneous, cryoablation, includes imaging guidance; lower extremity distal/peripheral nerveVirginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0442TAblation, percutaneous, cryoablation, includes imaging guidance; nerve plexus or other truncal nerve (eg, brachial plexus, pudendal nerve)Virginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0444UOncology (solid organ neoplasia), targeted genomic sequence analysis panel of 361 genes, interrogation for gene fusions, translocations, or other rearrangements, using DNA froVirginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy
0449TInsertion of aqueous drainage device, without extraocular reservoir, internal approach, into the subconjunctival space; initial deviceVirginia PPO standard precertification/prior authorization requirements, Pg 7 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.